Clearstead Advisors’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.4K | Buy |
1,026
+708
| +223% | +$23K | ﹤0.01% | 1420 |
|
|
2025
Q1 | $12K | Buy |
318
+158
| +99% | +$5.97K | ﹤0.01% | 1560 |
|
|
2024
Q4 | $13.1K | Sell |
160
-745
| -82% | -$61K | ﹤0.01% | 1505 |
|
|
2024
Q3 | $103K | Buy |
905
+16
| +2% | +$1.83K | ﹤0.01% | 1021 |
|
|
2024
Q2 | $67.1K | Buy |
889
+114
| +15% | +$8.61K | ﹤0.01% | 1091 |
|
|
2024
Q1 | $50.9K | Buy |
775
+235
| +44% | +$15.4K | ﹤0.01% | 754 |
|
|
2023
Q4 | $33.9K | Sell |
540
-280
| -34% | -$17.6K | ﹤0.01% | 834 |
|
|
2023
Q3 | $41.8K | Buy |
+820
| New | +$41.8K | ﹤0.01% | 910 |
|